What Is Semaglutide? A Simple Overview

Where Did Semaglutide Come From?

Semaglutide is a synthetic version of a naturally occurring hormone called GLP-1 (glucagon-like peptide-1). It was developed by Novo Nordisk® and first approved in the United States in 2017 under the brand name Ozempic®, for the treatment of type 2 diabetes.

Since then, different semaglutide formulations have been approved for different uses. For example:

• Ozempic®: FDA-approved for type 2 diabetes
  
• Wegovy®: FDA-approved for chronic weight management
  
• Rybelsus®: FDA-approved oral tablet for type 2 diabetes
  
  

Each version is designed for a specific indication, and a licensed healthcare provider is responsible for evaluating which one, if any, is suitable for you.

‍

{{primary-cta}}

‍

How Semaglutide Works

Semaglutide is part of a class of medications known as GLP-1 receptor agonists. Rather than replacing natural GLP-1, these medications are designed to enhance or mimic its effects in the body, supporting functions like blood sugar regulation, insulin release, and feelings of fullness.

When activated, GLP-1 receptors may help:

• Slow the rate at which food leaves the stomach
  
• Stimulate insulin release (when glucose is present)
  
• Reduce appetite in some individuals
  
  

A 2021 study published in The New England Journal of Medicine demonstrated that participants taking semaglutide experienced significant changes in appetite and body weight, particularly when paired with nutrition and lifestyle counseling.

These effects are why semaglutide is being explored in both diabetes and weight management contexts. However, treatment decisions must be made by a licensed healthcare provider based on a full clinical review.

‍

Understanding Semaglutide Delivery Options

Semaglutide is available in multiple FDA-approved formats as mentioned above, each developed for specific treatment goals and patient needs. Although the active ingredient remains the same, the method of delivery, dosing schedule, and approved use can vary.

A licensed healthcare provider will assess factors like your medical history, personal preferences, and treatment goals to determine which option, if any, may be appropriate. Whether it’s a daily tablet or a weekly injection, the delivery method should support both your lifestyle and clinical needs.

‍

{{primary-cta}}

‍

Is Semaglutide Right for Everyone?

Semaglutide is not for everyone, and it requires a licensed healthcare provider to assess whether it may be a safe and appropriate option. Providers will consider factors like:

• Your medical history
  
• Any current medications
  
• Metabolic health indicators
  
• Your preferences for injections versus tablets
  
  

It's important to have a complete clinical evaluation before starting any program that may include semaglutide. Eden makes that process easier by helping you connect with independent providers experienced in metabolic health.

‍

What to Expect If You’re Prescribed Semaglutide

If a licensed provider determines that semaglutide may be appropriate, they will typically start you on a low dose and gradually increase it over time. This stepwise approach is often used to potentially minimize common side effects such as nausea or digestive discomfort.

Providers will also offer guidance on how to take your medication, how to track progress, and when to follow up. Regular check-ins are key to making sure the treatment remains safe and effective based on your response.

‍

{{primary-cta}}

‍

How Eden Supports Your Journey

Eden is a digital health platform designed to improve access to licensed care for individuals exploring treatment options for metabolic health. Eden does not manufacture or sell medications and is not a provider.

Instead, Eden connects you with independent, licensed healthcare professionals who can evaluate your health history and determine whether semaglutide or another approach may be right for you. If prescribed, medications are dispensed through state-licensed pharmacies and delivered to your door.

You also get access to ongoing support and check-ins to help stay consistent with your treatment goals.

‍

Conclusion

Semaglutide is a GLP-1 receptor agonist with a growing presence in the conversation around metabolic health. Whether taken as a weekly injection or daily tablet, it works by activating biological pathways that may impact blood sugar, appetite, and digestion.

However, semaglutide is not a one-size-fits-all solution. A licensed healthcare provider is the only person who can determine if it is safe and appropriate based on your needs.

Eden helps you take the next step by connecting you with experienced providers who understand this space and can help guide your decisions with clarity.

Interested in Semaglutide? Connect with a licensed provider to learn whether a treatment program may be right for you.